Build your deal flow with startup briefs,
traction signals, and exit intelligence.
DealBio helps investors source health and longevity startups, follow their progress, and learn from acquisitions and IPOs.
Investor-focused research on health and longevity startups, covering what they are building, who is behind them, and how far they have progressed.
Ongoing updates showing which startups are gaining momentum.
Sobriety platform's free trial signups nearly double over 30 days.
Building a sobriety platform combining peer support, AI, and therapy.
Mobile MRI startup joins the portfolio of Robinhood Ventures Fund II, the Y Combinator-focused fund that began NYSE trading on 13 August.
Making compact mobile MRI screening accessible outside traditional imaging centers.
Health testing marketplace launches clinical-grade 30x whole genome sequencing, with members receiving a downloadable genome file they own.
Offering at-cost biomarker testing with AI-guided preventive health insights.
HYBRD passes 5 million workouts logged by its athletes.
Building coaching agents for hybrid athletes.
Health testing marketplace launches 10 allergy and exposure panels alongside 600+ individual tests spanning food, environmental, and venom triggers.
Offering at-cost biomarker testing with AI-guided preventive health insights.
Athletes using the app's AI coach retain and convert to paying customers at more than four times the rate of athletes who do not use it.
Building coaching agents for hybrid athletes.
Hybrid-training app launches on Apple Watch, sending planned workouts to the wrist and adapting them to what users finish.
Building coaching agents for hybrid athletes.
NOXXEA’s first prospective real-world clinical study reported a mean 7.32-point reduction in Insomnia Severity Index scores after four weeks of treatment.
Building Noxxea, a digital medicine for chronic insomnia.
At-home diagnostics startup secured €5M in financing, comprising €3M in equity led by Blue Forest Ventures and €2M in non-dilutive funding.
Building rapid point-of-need molecular diagnostics for early Lyme disease detection.
CNS gene-delivery startup wins Servier x BioLabs Golden Ticket for its blood-brain barrier delivery platform.
Using focused ultrasound and microbubbles to help gene therapies reach the brain.
Granza Bio wins Best Pitch and Best Scientific Explanation at the 2026 BioEscalator Pitch Battle.
Reprogramming immunity to create target-specific medicines.
Flex Capital invests in Ditto Bio’s evolutionary intelligence platform for autoimmune disease.
Discovering autoimmune-disease drugs from parasite immune-evasion biology.
Early Lyme test hits Boston subway ads to recruit patients after tick bites.
Building rapid point-of-need molecular diagnostics for early Lyme disease detection.
Health testing marketplace launches on Product Hunt with Y Combinator CEO Garry Tan as hunter.
Offering at-cost biomarker testing with AI-guided preventive health insights.
HYBRD blows past 500 five-star App Store reviews.
Building coaching agents for hybrid athletes.
A selection of health and longevity startups, researched for investors.
Explore acquisitions and IPOs across health and longevity, including transaction values, acquirers, and time to exit.
Developed rapid blood tests that detected sepsis-causing bacteria and fungi directly from whole blood.
Developed HIV drugs and resistance tests that helped doctors choose treatments more likely to work.
Built connected scales, watches, and health monitors that automatically turned everyday measurements into usable health insights.
Combined connected devices, personalized guidance, and coaching to help people manage diabetes and other chronic conditions.
Offered at-home hormone tests that helped women understand fertility, ovarian reserve, and reproductive planning.
Developed fish-skin grafts that help the body repair chronic, diabetic, burn, surgical, and trauma wounds.
Provided direct-to-consumer delivery of catheters and ostomy supplies across the United States.
Developed minimally invasive surgical products for female stress urinary incontinence and pelvic organ prolapse.
Developed compact PCR tests that delivered rapid molecular results near patients with infectious diseases.
Developed genomic tests that assessed prostate cancer risk and helped clinicians guide treatment decisions.
Developed blood and tissue genomic tests that profiled cancers and helped guide targeted treatments.
Developed collagen implants that supported tendon and ligament healing after orthopedic and sports injuries.
Offered virtual primary and urgent care for diagnosis, prescriptions, and ongoing treatment from home.
Developed connected inhaler sensors and software that helped manage asthma and chronic lung disease.
Built a food and exercise tracking app that helped users monitor calories, nutrition, weight, and activity.
Offered virtual weight-management care combining clinician visits, medication access, and ongoing coaching.
Developed vitamins, minerals, and supplements sold through healthcare practitioners and consumer channels.
Developed robotic systems that helped physicians diagnose and treat disease through minimally invasive procedures.
Developed real-time ultrasound systems that helped surgeons visualize anatomy and guide decisions during operations.
Developed wearable cardiac monitors and remote services that detected irregular heart rhythms outside hospitals.
Developed automated pharmacy systems that helped hospitals store, package, track, and dispense medications safely.
Developed a non-hormonal therapy designed to reduce hot flashes and other symptoms of menopause.
Developed small-molecule therapies targeting neurokinin pathways to treat menopause and hormone-related conditions.
Offered microbiome sequencing and analysis services that helped researchers measure microbial communities.
Offered inpatient and outpatient treatment for addiction and behavioral health conditions across care centers.
Built oncology software and real-world data tools that supported cancer care and treatment research.
Developed blood-based genomic tests designed to detect multiple cancers before symptoms appeared.
Offered clinical genetic tests that identified inherited disease risks and guided personalized care decisions.
Developed genomic testing tools that helped laboratories detect cancer mutations and guide targeted treatments.
Developed gene therapies for retinal diseases by targeting biological pathways involved in vision loss.
Developed stem-cell gene therapies designed to give people with HIV long-lasting resistance to the virus.
Developed antiviral medicines for respiratory syncytial virus in infants and other vulnerable patients.
Developed antiviral medicines for respiratory syncytial virus and other infections affecting infants and adults.
Developed AI software that analyzed medical images to help clinicians detect and prioritize suspected conditions.
Developed a non-steroidal topical medicine for treating plaque psoriasis and atopic dermatitis.
Developed capsules, formulation technologies, and manufacturing services used to produce and deliver medicines.
Developed injectable medicines targeting metabolic diseases, including obesity and diabetes.
Developed reproductive genetic tests that helped IVF clinics assess embryos, fertility risks, and pregnancy outcomes.
Offered donor reproductive tissue, fertility preservation, and newborn stem-cell storage for families and clinics.
Developed a connected home-fitness mirror that delivered live and on-demand exercise classes.
Developed mobile fitness-tracking and training apps connected to smartphones and wearable devices.
Built a mobile training app that tracked workouts and provided social and coaching features for active users.
Developed genomic tumor profiling tests that helped clinicians select targeted cancer treatments and trials.
Developed implantable nerve-stimulation systems that helped treat bladder and bowel control disorders.
Developed spinal cord stimulation systems that used electrical pulses to help patients manage chronic pain.
Developed spinal implants and surgical tools that helped clinicians treat complex spine disorders.
Built a healthcare navigation platform that helped employees understand benefits and access appropriate care.
Offered primary care for older adults, coordinating preventive, chronic, and social support services.
Developed antibody-drug conjugates that delivered cancer medicines more directly to tumor cells.
Developed targeted cancer medicines matched to tumor mutations rather than the cancer's organ of origin.
Developed robotic systems that helped surgeons plan and perform knee and hip replacement procedures.
Developed software that helped hospitals and radiologists store, manage, and analyze medical images.
Developed medicines that helped treat schizophrenia, bipolar depression, and other brain disorders.
Developed muscarinic receptor medicines to treat schizophrenia and other neurological conditions.
Developed medicines for postpartum depression and other brain conditions involving disrupted signaling.
Developed gene replacement therapy that addressed the underlying cause of spinal muscular atrophy.
Developed CAR-T therapies that reprogrammed patients' immune cells to recognize and attack cancer.
Developed CAR-T therapies that used patients' engineered immune cells to treat blood cancers.
Developed targeted medicines for autoimmune and inflammatory diseases caused by abnormal immune responses.
Offered clinical research services that helped drug developers plan and run clinical trials.
Developed wearable devices and software that tracked activity, sleep, heart rate, and health trends.
Developed cancer medicines that used antibodies to carry protein-degrading drugs directly into tumor cells.
Developed long-acting antibody medicines designed to relieve chronic itch and inflammatory skin disease.
Developed an oral medicine that blocked a tumor-growth protein to treat kidney cancer.
Developed small molecules designed to reverse the immune suppression that protects tumors.
Developed cartridge-based PCR systems that delivered rapid molecular test results near patients.
Developed gene therapies delivered into the brain for Parkinson's disease and other neurodegenerative conditions.
Developed robotic guidance systems that helped surgeons place implants during spine operations.
Developed gene expression tests that predicted cancer recurrence and guided chemotherapy decisions.
Offered membership-based primary care combining in-office visits, on-site labs and virtual care.
Sold at-home biomarker tests alongside supplements, using results to personalize recommendations.
Managed fertility and family-building benefits sold to self-insured employers.
Developed small-molecule medicines designed to calm the immune system in inflammatory conditions.
Developed an oral medicine designed to work alongside standard treatment for a rare bone-marrow cancer.
Developed an antibody treatment for a virus that attacks the kidney in transplant patients.
